A Phase I/II Study for Analytic Validation of (89)Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

PURPOSE: Standard imaging for assessing osseous metastases in advanced prostate cancer remains focused on altered bone metabolism and is inadequate for diagnostic, prognostic, or predictive purposes. We performed a first-in-human phase I/II study of (89)Zr-DFO-huJ591 ((89)Zr-J591) PET/CT immunoscint...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Pandit-Taskar, Neeta, O'Donoghue, Joseph A., Durack, Jeremy C., Lyashchenko, Serge K., Cheal, Sarah M., Beylergil, Volkan, Lefkowitz, Robert A., Carrasquillo, Jorge A., Martinez, Danny F., Fung, Alex Mak, Solomon, Stephen B., Gonen, Mithat, Heller, Glenn, Loda, Massimo, Nanus, David M., Tagawa, Scott T., Feldman, Jarett L., Osborne, Joseph R., Lewis, Jason S., Reuter, Victor E., Weber, Wolfgang A., Bander, Neil H., Scher, Howard I., Larson, Steven M., Morris, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668231/
https://ncbi.nlm.nih.gov/pubmed/26175541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0552
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados